This statistic shows the estimated average per-patient clinical trial costs in the United States in 2013, by phase. That year clinical trials for new medicines for the biopharmaceutical industry cost an average of 36,500 dollars for all phases.
Average per-patient biopharmaceutical clinical trial costs in the U.S. 2013, by phase
Average cost per patient in biopharmaceutical clinical trials in the United States in 2013, by phase
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Average per-patient clinical trial costs in U.S. 2013, by selected condition
- States with the most biopharmaceutical clinical trials in the U.S. in 2013
- U.S. states with the most participants in biopharmaceutical clinical trials 2013
- Economic impact of biopharmaceutical industry-sponsored clinical trials U.S. 2013
- Number of biopharmaceutical clinical trial participants U.S. 2013, by disease area
- Number of biopharmaceutical industry-sponsored clinical trials U.S. 2013, by phase
- Number of biopharmaceutical clinical trial participants in the U.S. 2013, by phase
- Number of biopharmaceutical clinical trials in the U.S. 2013, by selected disease
- Select supply chain technologies utilized by clinical trial organizations 2016
- Investments made by clinical research organizations by phase 2009-2014
- Impact of clinical trials on the daily lives of participants globally 2017
- Annual compensation in U.S. biopharmaceutical industry vs. national average 2015
- Average per-study costs by trial phase
- Reasons why clinical trial organizations use direct-to-patient distribution 2016
- Logistics methods utilized for clinical trials by drug supply stage 2016
- Employees in biopharmaceutical industry in South Korea 2016, by position
- Participation in clinical trials among U.S. adults and family 2017
PhRMA. (March 12, 2015). Average cost per patient in biopharmaceutical clinical trials in the United States in 2013, by phase [Graph]. In Statista. Retrieved December 08, 2019, from https://www.statista.com/statistics/645490/per-patient-clinical-trial-costs-in-us/
PhRMA. "Average cost per patient in biopharmaceutical clinical trials in the United States in 2013, by phase." Chart. March 12, 2015. Statista. Accessed December 08, 2019. https://www.statista.com/statistics/645490/per-patient-clinical-trial-costs-in-us/
PhRMA. (2015). Average cost per patient in biopharmaceutical clinical trials in the United States in 2013, by phase. Statista. Statista Inc.. Accessed: December 08, 2019. https://www.statista.com/statistics/645490/per-patient-clinical-trial-costs-in-us/
PhRMA. "Average Cost per Patient in Biopharmaceutical Clinical Trials in The United States in 2013, by Phase." Statista, Statista Inc., 12 Mar 2015, https://www.statista.com/statistics/645490/per-patient-clinical-trial-costs-in-us/
PhRMA, Average cost per patient in biopharmaceutical clinical trials in the United States in 2013, by phase Statista, https://www.statista.com/statistics/645490/per-patient-clinical-trial-costs-in-us/ (last visited December 08, 2019)